Cargando…
A potential role for daptomycin in enterococcal infections: what is the evidence?
Nosocomial infections caused by enterococci present a challenge for clinicians because treatment options are often limited due to the widespread occurrence of strains resistant to multiple antibiotics, including vancomycin. Daptomycin is a first-in-class cyclic lipopeptide that has proven efficacy f...
Autores principales: | Cantón, Rafael, Ruiz-Garbajosa, Patricia, Chaves, Ricardo L., Johnson, Alan P. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868529/ https://www.ncbi.nlm.nih.gov/pubmed/20363805 http://dx.doi.org/10.1093/jac/dkq087 |
Ejemplares similares
-
De Novo Daptomycin-Nonsusceptible Enterococcal Infections
por: Kelesidis, Theodoros, et al.
Publicado: (2012) -
The effects of daptomycin on cell wall biosynthesis in Enterococcal faecalis
por: Rimal, Binayak, et al.
Publicado: (2023) -
Comparison of linezolid and daptomycin for the treatment of vancomycin-resistant enterococcal bacteremia
por: Narayanan, Navaneeth, et al.
Publicado: (2019) -
A rationale for combination ampicillin and daptomycin in renal transplant patients with enterococcal infective endocarditis
por: Castro-Lainez, Miriams Teresita, et al.
Publicado: (2018) -
1045 Linezolid Compared to Daptomycin for the Treatment of Vancomycin-resistant Enterococcal Urinary Tract Infections
por: Moenster, Ryan P., et al.
Publicado: (2014)